Jin Medical International Ltd.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $20.7M | $23.5M | $19.8M | $19.2M | $20.8M |
| Cost of Revenue | $14.6M | $14.0M | $13.0M | $13.0M | $14.4M |
| Gross Profit | $6.0M | $9.5M | $6.8M | $6.2M | $6.4M |
| Gross Margin | 29.2% | 40.4% | 34.2% | 32.3% | 30.6% |
| Operating Expenses | |||||
| Research & Development | $1.6M | $1.5M | $1.5M | $1.9M | $1.6M |
| SG&A Expense | $2.5M | $3.3M | $1.9M | $1.8M | $1.7M |
| Operating Income | $608.2K | $3.6M | $2.9M | $2.1M | $2.6M |
| Operating Margin | 2.9% | 15.5% | 14.5% | 11.1% | 12.7% |
| Interest Expense | — | — | — | — | — |
| Pretax Income | $1.6M | $4.2M | $3.2M | $2.7M | $2.9M |
| Income Tax Expense | $214.6K | $763.9K | $343.7K | $36.1K | $248.6K |
| Net Income | $1.2M | $3.7M | $2.9M | $2.7M | $2.6M |
| Net Margin | 5.8% | 15.6% | 14.5% | 14.1% | 12.7% |
| EPS (Basic) | $0.01 | $0.02 | $0.02 | $0.02 | $0.02 |
| EPS (Diluted) | $0.01 | $0.02 | $0.02 | $0.02 | $0.02 |
| Shares Outstanding (Basic) | 156.5M | 156.5M | 145.1M | 135.0M | 135.0M |
| Shares Outstanding (Diluted) | 156.5M | 156.5M | 145.1M | 135.0M | 135.0M |
| Dividends Per Share | — | — | — | — | — |